Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists may increase the risk of hair loss, especially non-scarring types, due to weight loss-related nutrient deficiencies.

GLP-1 receptor agonists increase the risk of hair loss, mainly due to weight loss-related nutrient deficiency.

GLP-1 receptor agonists increase the risk of hair loss, mainly due to nutrient deficiency from weight loss.

GLP-1 RAs may help wound healing but can also cause faster facial aging and skin issues.

Methylene blue helps hair growth by protecting hair stem cells from stress.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

The nutritional supplement Pilopeptan® WOMAN improved hair growth and thickness in women with hair loss.

GLP1-RAs may have higher reports of suicidal events and hair loss compared to other diabetes drugs.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Methylene blue, combined with ceramides, may reduce skin and hair side effects from GLP-1 therapy.

The new scaffold with two growth factors speeds up skin healing and reduces scarring.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

Men generally have higher blood pressure than premenopausal women, but postmenopausal women's blood pressure can surpass men's, and hormone therapy doesn't significantly help.

Antioxidants might help manage Long Covid by addressing oxidative stress and nutrient imbalances.

The conclusion suggests that managing antioxidant levels and the calcium to magnesium ratio may help address Long Covid and related chronic fatigue conditions.

Individualized treatments may help manage Dercum's disease symptoms.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Normal cells outcompete and remove mutant cells in the pancreas with the help of the EphA2 receptor.

Loss of Dnmt3a and Dnmt3b leads to more aggressive skin tumors, but blocking PPAR-γ can reduce this effect.

ERK activation spreads between cells in mouse skin, linked to cell division and influenced by TPA and EGF receptors.

ERK activation spreads between cells, influencing cell division and wound healing.

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

XEDAR triggers a specific signaling pathway in cells.

EREG therapy may help treat hair loss by promoting hair growth.

A specific molecular switch, driven by MAPK/ERK signaling, helps spiny mice heal wounds by regenerating skin instead of forming scars.

Stem cells control their future role by changing ERK signal timing, affecting tissue regeneration and cancer.

RhoA helps skin stem cells grow, aiding wound healing.

Normal skin cell renewal doesn't need RAR signaling, but vitamin A-related skin thickening does.

Epiregulin can help hair grow and may be useful for treating hair loss.